Related Experiment Video
Updated: May 16, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Long-Term Outcomes of Paroxysmal and Persistent Atrial Fibrillation Management Strategy During Nonemergent Coronary
Robert B Hawkins1, Boateng Kubi2, Raymond John Strobel3
1Division of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan.
Insights
Management of atrial fibrillation (AF) during coronary artery bypass grafting (CABG) is crucial. Epicardial ablation demonstrated superior long-term survival, while all AF treatments reduced stroke risk in CABG patients.
Area of Science:
- Cardiology
- Cardiac Surgery
- Electrophysiology
Background:
- Atrial fibrillation (AF) management during coronary artery bypass grafting (CABG) is a Class 1 recommendation.
- This study investigates trends in AF treatment and their impact on long-term survival.
- A significant proportion of AF patients undergoing CABG remain untreated.
Purpose of the Study:
- To evaluate trends in AF management strategies during CABG.
- To assess the association between different AF treatments and long-term patient survival.
- To analyze the impact of AF management on secondary outcomes like stroke and pacemaker placement.
Main Methods:
- Analysis of 59,331 patients with AF undergoing isolated CABG (2011-2022) from the STS Adult Cardiac Surgery Database linked to Medicare claims.
- Stratification of patients based on AF treatment: none, left atrial appendage occlusion (LAAO) only, epicardial ablation (EA), or intracardiac ablation (IA).
- Kaplan-Meier and Cox regression for mortality; competing-risk regression for nonfatal outcomes (stroke, pacemaker placement, readmissions).
Main Results:
- AF treatment rates increased from 31.8% to 68.8%, largely driven by LAAO.
- Persistent AF was associated with higher mortality than paroxysmal AF.
- Epicardial ablation (EA) showed lower mortality than no treatment; all treatment groups had reduced stroke risk and AF readmissions.
- Intracardiac ablation (IA) was linked to higher pacemaker implantation rates.
Conclusions:
- Nearly half of AF patients undergoing CABG do not receive AF-specific treatment.
- Epicardial ablation is associated with superior long-term survival post-CABG.
- All evaluated AF management strategies, including LAAO and ablation, offer reduced stroke risk and AF readmissions.
Background:
Management of atrial fibrillation (AF) at the time of coronary artery bypass grafting (CABG) is a class 1 recommendation. This study evaluated trends in AF management and their association with long-term survival.
Methods:
Patients with paroxysmal or persistent AF who underwent isolated CABG were identified from The Society of Thoracic Surgeons Adult Cardiac Surgery Database (2011-2022) with linkage to Medicare claims for long-term outcomes. Patients were stratified by AF treatment: none, left atrial appendage occlusion (LAAO) only, epicardial ablation (EA), or intracardiac ablation (IA). The primary end point was all-cause mortality; secondary end points included permanent pacemaker placement, stroke, and readmission for AF, bleeding, or heart failure. Long-term mortality was assessed using Kaplan-Meier methods and Cox regression. Nonfatal outcomes were assessed using competing-risk regression with death as the competing event.
Results:
Among 59,331 patients, 71.0% had paroxysmal AF, increasing from 56.6% (2011) to 79.6% (2022). AF treatment included none (51.0%), LAAO only (15.3%), EA (25.4%), and IA (8.2%). AF treatment increased from 31.8% to 68.8%, driven by LAAO (1.2%-30.8%). Patients with persistent AF had higher mortality than patients with paroxysmal AF (P < .001). EA showed lower mortality compared with no treatment. IA was associated with higher pacemaker implantation (6.0% vs 3.2%-3.4% in other groups; P < .001). Compared with no treatment, all treatment groups had lower stroke risk (subdistribution hazard ratio, 0.64-0.79; P < .001) and lower AF readmission (subdistribution hazard ratio, 0.85-0.89; P < .05).
Conclusions:
Nearly one-half of patients with AF who underwent CABG receive no treatment. Epicardial ablation was associated with superior long-term survival, and all strategies with were associated lower stroke risk.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Aneurysm IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Coronary Artery Disease V: Interprofessional Care
Aortic Regurgitation III: Medical Management

